CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · IEX Real-Time Price · USD
19.09
+0.09 (0.47%)
May 10, 2024, 4:00 PM EDT - Market closed
CARGO Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for CARGO Therapeutics stock have an average target of 29.67, with a low estimate of 23 and a high estimate of 34. The average target predicts an increase of 55.42% from the current stock price of 19.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
The average analyst rating for CRGX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $28 → $32 | Strong Buy | Maintains | $28 → $32 | +67.63% | Mar 22, 2024 |
| Truist Securities | Truist Securities | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +78.10% | Dec 5, 2023 |
| TD Cowen | TD Cowen | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 5, 2023 |
| JP Morgan | JP Morgan | Buy Initiates $23 | Buy | Initiates | $23 | +20.48% | Dec 5, 2023 |
| Jefferies | Jefferies | Strong Buy Initiates $28 | Strong Buy | Initiates | $28 | +46.67% | Dec 5, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.61
from -16.53
EPS Next Year
-4.94
from -5.61
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 31.5M | 301.4M | 393.8M |
| Avg | n/a | n/a | 30.6M | 238.2M | 368.3M |
| Low | n/a | n/a | 29.4M | 176.4M | 340.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 885.1% | 65.3% |
| Avg | - | - | - | 678.5% | 54.6% |
| Low | - | - | - | 476.5% | 42.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -4.41 | -4.52 | -4.78 |
| Avg | -5.61 | -4.94 | -4.64 |
| Low | -6.10 | -5.28 | -4.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.